Markus Richard, Chief Medical Officer of Arcus Biosciences, Inc. ($RCUS), sold common shares on the open market twice in the last 365 days, totaling about $210 thousand. His most recent sale occurred on December 17, 2025. These transactions rank 8,313th among 11,678 individual insiders, below the average sale amount of $8.6 million across 6.4 transactions. Richard made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2026 | Arcus Biosciences, Inc. | $RCUS | Markus Richard | Chief Medical Officer | A | Common Stock | 24000 | $0.00 | 89,647.0000 | 107,973,536 | 36.56% | 0.02% |
| Jan. 23, 2026 | Arcus Biosciences, Inc. | $RCUS | Markus Richard | Chief Medical Officer | A | Stock Option (right to buy) | 96000 | $0.00 | 96,000.0000 | 107,973,536 | 9999.99% | 0.09% |
| Dec. 16, 2025 | Arcus Biosciences, Inc. | $RCUS | Markus Richard | Chief Medical Officer | S | Common Stock | 5052 | $21.88 | 70,141.0000 | 107,973,536 | 6.72% | 0.00% |
| Dec. 17, 2025 | Arcus Biosciences, Inc. | $RCUS | Markus Richard | Chief Medical Officer | S | Common Stock | 4494 | $22.16 | 65,647.0000 | 107,973,536 | 6.41% | 0.00% |
| Feb. 10, 2025 | Arcus Biosciences, Inc. | $RCUS | Markus Richard | Chief Medical Officer | A | Common Stock | 75193 | $0.00 | 75,193.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | Arcus Biosciences, Inc. | $RCUS | Markus Richard | Chief Medical Officer | A | Stock Option (right to buy) | 305328 | $0.00 | 305,328.0000 | 0 | 9999.99% | 0.00% |